BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liang C, Wu HM, Yu WM, Chen W. Research status on immunotherapy trials of gastric cancer. World J Clin Cases 2021; 9(21): 5782-5793 [PMID: 34368297 DOI: 10.12998/wjcc.v9.i21.5782]
URL: https://www.wjgnet.com/1007-9327/full/v9/i21/5782.htm
Number Citing Articles
1
Min Fu, Yongbiao Huang, Xiaohong Peng, Xiaoyu Li, Na Luo, Wenjun Zhu, Feng Yang, Ziqi Chen, Shengling Ma, Yuanyuan Zhang, Qianxia Li, Guangyuan Hu. Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.790920
2
Fei Jiang, Xiaowei Chen, Yan Shen, Xiaobing Shen. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway–Related Prognostic Prediction Model in Gastric CancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.891744
3
Li Xiang, Chuan Lan, Luca Falzone. Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer PatientsInternational Journal of Genomics 2022; 2022: 1 doi: 10.1155/2022/7684606
4
Safia Samir, Hend Okasha Ahmed, Tarek M. Diab, Amr Mostafa, Hesham A. Elmeligy, Amira Kamel, Heba Khalil. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 ImmunoreactivityOpen Access Macedonian Journal of Medical Sciences 2022; 10(A): 1218 doi: 10.3889/oamjms.2022.9700
5
Youngdong Choi, Hong Kyu Lee, Dohee Ahn, Min-Woo Nam, Ryeo-Eun Go, Kyung-Chul Choi. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse modelLife Sciences 2023; 328: 121866 doi: 10.1016/j.lfs.2023.121866
6
Ning Li, Zhi Li, Qiang Fu, Bin Zhang, Jian Zhang, Xiang-Bin Wan, Chao-Min Lu, Jin-Bang Wang, Wen-Ying Deng, Yi-Jie Ma, Liang-Yu Bie, Meng-Yu Wang, Jing Li, Qing-Xin Xia, Chen Wei, Su-Xia Luo. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II studyInternational Journal of Surgery 2024; 110(4): 2071 doi: 10.1097/JS9.0000000000001119